Management ChangeMay 12, 2026, 08:02 AM
Humacyte Appoints Todd E. Rasmussen as Chief Surgical Officer
AI Summary
Humacyte, Inc. announced the appointment of Todd E. Rasmussen, M.D., as its new Chief Surgical Officer. Dr. Rasmussen, a distinguished vascular surgeon with decades of clinical experience from the U.S. Air Force and Mayo Clinic, will focus on providing scientific support, medical education, and technical insights to healthcare providers. This strategic appointment is expected to bring important surgical perspective to Humacyte's leadership as the clinical adoption of Symvess® ramps up and pipeline indications move toward approval.
Key Highlights
- Humacyte appointed Todd E. Rasmussen, M.D., as Chief Surgical Officer.
- Dr. Rasmussen will provide peer-to-peer scientific support and medical education to surgeons.
- He brings extensive experience as a vascular surgeon from the U.S. Air Force and Mayo Clinic.
- His role is crucial for guiding strategy and real-world implementation of Humacyte products.
- Dr. Rasmussen will continue his clinical, educational, and administrative responsibilities at Mayo Clinic.
- Mayo Clinic has a financial interest in Humacyte.
Price Impact
More from HUMA